FGF401 potentiates the antitumor activity of vinorelbine to inhibit tumor growth, cell proliferation and positive cell cycle regulators and prolongs the survival of mice bearing high FGF19-expressing HCC tumors. This evidence concerns the gene FGF19 and neoplasm.